ACADIAN ASSET MANAGEMENT LLC - HARPOON THERAPEUTICS INC ownership

HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 70 filers reported holding HARPOON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of HARPOON THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$53
-36.9%
76,710
-32.5%
0.00%
Q1 2023$84
-7.7%
113,702
-10.4%
0.00%
Q4 2022$91
-99.8%
126,954
+124.2%
0.00%
Q3 2022$54,000
-50.5%
56,6350.0%0.00%
-100.0%
Q2 2022$109,000
-65.7%
56,635
+147.0%
0.00%0.0%
Q2 2021$318,000
-69.0%
22,933
-53.3%
0.00%
-75.0%
Q1 2021$1,026,000
+71.6%
49,066
+36.4%
0.00%
+100.0%
Q4 2020$598,000
+79.0%
35,968
+82.6%
0.00%
+100.0%
Q3 2020$334,000
-10.9%
19,702
-12.8%
0.00%
-50.0%
Q2 2020$375,000
+316.7%
22,595
+189.5%
0.00%
+100.0%
Q1 2020$90,0007,8060.00%
Other shareholders
HARPOON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,524,425$58,818,00023.77%
New Leaf Venture Partners, L.L.C. 2,921,405$37,978,00010.18%
EcoR1 Capital, LLC 1,348,423$17,529,0001.77%
SPHERA FUNDS MANAGEMENT LTD. 374,031$4,862,0000.66%
Orbimed Advisors 2,446,409$31,803,0000.49%
Cormorant Asset Management, LP 649,994$8,450,0000.48%
Fosun International Ltd 323,400$4,205,0000.28%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 285,000$3,705,0000.13%
Baker Brothers Advisors 214,285$2,786,0000.02%
UBS Group AG 1,062$14,0000.00%
View complete list of HARPOON THERAPEUTICS INC shareholders